Jason Adair

Corporate Officer/Principal presso Liquidia Technologies, Inc.

Patrimonio netto: 1 M $ in data 30/06/2024

Health Technology

Consumer Services

Posizioni attive di Jason Adair

Società	Posizione	Inizio	Fine
Liquidia Technologies, Inc. Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC.	Corporate Officer/Principal	14/01/2016	-

Società	Posizione	Inizio	Fine
BIOCRYST PHARMACEUTICALS, INC.	Corporate Officer/Principal	01/08/2011	01/12/2015
LIQUIDIA CORPORATION	Contatto Relazioni con gli Investitori	-	-
	Public Communications Contact	-	-
	Corporate Officer/Principal	-	-

Wake Forest University	Undergraduate Degree
Tuck School of Business at Dartmouth	Masters Business Admin

Distribuzione geografica

Stati Uniti

Posizioni

Corporate Officer/Principal	3
Undergraduate Degree	1
Masters Business Admin	1

Settori

Health Technology	4
Consumer Services	3

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	2
BIOCRYST PHARMACEUTICALS, INC.	Health Technology
LIQUIDIA CORPORATION	Health Technology

Aziende private	1
Liquidia Technologies, Inc. Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC.	Health Technology

Aziende private

Health Technology